| Peer-Reviewed

Prevalence and Risk Factors of Hepatitis C Viral Infection Among Pregnant Women at a Tertiary Institution in Lagos, Nigeria

Received: 26 January 2023    Accepted: 17 February 2023    Published: 28 February 2023
Views:       Downloads:
Abstract

Hepatitis C viral infection is a blood borne disease caused by Hepatitis C virus (HCV). It is significantly associated with morbidities and mortalities in men and women. Infection mostly occurs via contact with blood from transfusion of unscreened blood as well as blood products, illicit parenteral drug use (sharing of injection needles), unsafe health care and injection practices. Women who are pregnant and their unborn babies and infants are among the group of people less commonly talked about when the disease burden of HCV is being discussed in Nigeria. This study therefore aimed to ascertain the prevalence of hepatitis C virus infection among the pregnant women as well as the risk factors associated with the acquisition of the infection. Four hundred consenting antenatal attendees at the Lagos Island Maternity hospital, Nigeria were recruited and their blood samples were taken for analysis. A pretested and validated semi structured questionnaire was used to obtain information on risk factors for Hepatitis C Virus infection and socio demographic characteristic of participants. Univariate analysis was performed to obtain proportions and frequencies. In order to uncover additional risk variables for HCV infection, bivariate data analysis was carried out. Chi-square test was performed to assess statistical significance which was assumed at 0.05%. The mean age of the study subjects were 30.6 years with a standard deviation of ± 5.0 years. Majority of the study subjects 133 (33.2%) were in the age group of 30-34, most of them 238 (59.5%) had tertiary education, 396 (99.0%) were married, 110 (27.5%) were traders and 329 (82.3%) were of monogamous family setting. There was an overall sero-prevalence of 1.5% among the pregnant women with a higher prevalence of 1.25% among pregnant women who had more than one delivery (multiparous women) and 0.25% among pregnant women who had no previous delivery (nulliparous women). The risk factors that were significantly associated with the transmission of HCV infection included “Tattoo/Scarification (P=0.002) and “sharing of sharps and needles” (P=0.015). There is the need for effective public education on the ways of spread of HCV virus, practice of universal precautionary measures, adequate sterilization of instruments, appropriate use of injections, safe disposal of waste and sharps and avoidance of other high risk behavior that may lead to HCV infection. A more lager studies on the epidemiology of HCV infection is needed to inform health policy makers on strategies for prevention, screening, control and treatment of HCV infection.

Published in International Journal of Infectious Diseases and Therapy (Volume 8, Issue 1)
DOI 10.11648/j.ijidt.20230801.13
Page(s) 23-30
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Hepatitis C Virus, Prevalence, Risk Factors, Pregnant Women

References
[1] Madhava, V., Burgess, C., Drucker, E. (2002). Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2 (5): 293–302. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270354/ (Accessed: 28 August 2022).
[2] Blach, S., Zeuzem, S., Manns, M, et al., (2015) Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterology & Hepatology, 2 (3), 161–176.
[3] World Health Organization, (2012) Prevention and Control of Viral Hepatitis Infection: Framework for Global Action, World Health Organization, Geneva, Switzerland.
[4] World Health Organization (2022) Hepatitis C’ Available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c (Accessed 28 August 2022).
[5] Razavi, H., ElKhoury, A. C., Elbasha, E., Estes, C., Pasini, K., Poynard, T., et al. (2013) Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology.; 57: 2164–2170.
[6] Anaedobe, C., Fowotade, A., Nwadike, V., & Ugochukwu, (2016). Hepatitis C Virus Infection among Pregnant Women in Ibadan, Nigeria: Prevalence, Correlates and Co-infection with HIV. Available at: https://journalijtdh.com/index.php/IJTDH/article/view/20292/37576 (Accessed 28 August 2022).
[7] Ford, N., Kirby, C., Singh, K., Mills, E. J., Cooke, G., & Kamarulzaman, A., et al. (2012) Chronic hepatitis C treatment outcomes in low- and middle-income countries: A systematic review and meta-analysis. Bull WHO; 90: 540–550.
[8] Arshad, M., El-Kamary, S. S., Jhaveri, R., (2011). Hepatitis C virus infection during pregnancy and the newborn period. J Viral Hepat. 18 (4), 229-236.
[9] Ward, C., Tudor-Williams, G., Cotzias, T., Hargreaves, S., Regan, L., Foster, G. R., (2000) Prevalence of hepatitis C among Pregnant Women attending an inner London Obstetric Department: Uptake and acceptability of named antenatal testing. Gut. 47 (2), 277-280.
[10] Wong, T., Lee, S. S., (2006). Hepatitis C: A review for primary care physicians. Canadian Medical Association Journal, 174 (5), 649-659.
[11] Antonella, V., Stefania, B., Pier-Angelo, T., (2008) Mother-to-child hepatitis C virus transmission. Hot Topics in Viral Hepat. 11: 7-11.
[12] Omunakwe, H. E., Dan-Jumbo, A., Abere, S. T., Kalio, G. B., & Oyan, B., (2019). The prevalence of hepatitis c viral among women undergoing antenatal care in Port Harcourt, Nigeria. Nigerian Journal of Gastroenterology and Hepatology 11 (1).
[13] Mboto, C. I., Ebenge, I. A., Ogban, I. E., Andrew, P. J., (2010) Prevalence, Sociodemographic Characteristics and Risk Factors for Hepatitis C Infection among Pregnant Women in Calabar Municipality, Nigeria Hepat Mon. Spring; 10 (2), 116–120. Online Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270354/ (Accessed 28 August 2022).
[14] Filani, M. O., (2012). The Changing Face of Lagos: From Vision to Reform and Transformation, 8–11.
[15] Sotunde, O. F., Sanni, S. A., Onabanjo, O. O., Olayiwola, I. O., & Agbonlahor, M. (2014). A retrospective study of the health profile of neonates of mothers with anemia in pregnancy and pregnancy induced hypertension in Lagos, Nigeria. Journal of Public Health in Africa, 5, 63–67. doi: 10.4081/jphia.2014.286
[16] Ogunro, P. S., Adekanle, D. A., Fadero, F. F., Ogungbamigbe, T. O., & Oninla, S. O. (2007). Prevalence of anti-hepatitis C virus antibodies in pregnant women and their offspring in a tertiary hospital in Southwestern Nigeria. J Infect Developing Countries, 1 (3), 333–336.
[17] Hanafiah, K. M., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013). Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology, 57 (4), 1333–1342.
[18] Onakewhor, J., & Okonofua, F. (2009). Seroprevalence of hepatitis c viral antidodies in pregnancy in a tertiary health facility in Nigeria. Nigerian Journal of Clinical Practice, 12 (March), 65–73. Retrieved from http://www.ajol.info/index.php/njcp/article/download/45364/28847
[19] Esan, A. J., Omisakin, C. T., Ojo-Bola, T., Owoseni, M. F., Fasakin, K. A., & Ogunleye, A. A. (2014). Sero-Prevalence of Hepatitis B and Hepatitis C Virue Co-Infection among Pregnant Women in Nigeria. American Journal of Biomedical Research, 2 (1), 11–15. doi: 10.12691/ajbr-2-1-3
[20] Oladeinde, B. H., Omoregie, R., Olley, M., Anunibe, J. A., & Oladeinde, O. (2012). Hepatitis B and C Viral Infections among Pregnant Women in a Rural Community of Nigeria. International Journal of Basic and Applied Virology 1, (1), (01–05, ISSN 2222–1298.
[21] Njouom, R., Pasquier, C., Ayouba, A., Tejiokem, M., Vessiere, A. Mfoupouendoun, J., Tene, G., Izopet, J. (2005). Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg, 73, 460 – 466.
[22] Kumar, A., Sharma, K. A., Gupta, R. K., Kar, P., & Chakravarti, A. (2007). Prevalence & risk factors for hepatitis C virus among pregnant women. Indian Journal of Medical Research, 126, 211–215.
[23] Buseri, F., Seiyabo, E., & Jeremiah, Z. (2010). Surveying infections among pregnant women in the Niger Delta, Nigeria. J. Global Infect Dis., 2, 203–211.
[24] Altinbas, S., Erdogan, M., & Danişman, N. (2010). The seroprevalences of HBs Ag and anti-HCV in pregnant women in Ankara. Arch Gynecol Obstet., 281, 371. doi: 10.1007/s00404-009-1145-6
[25] Elsheikh, R., Daak, A., Elsheikh, M., Karsany, M., & Adam, I. (2007). Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J., 4, 104. doi: 10.1186/1743-422X-4-104
[26] Ugbebor, O., Aigbirior, M., Osazuwa, F., Enabudoso, E., & Zabayo, O. (2011). The prevalence of hepatitis B and C viral infections among pregnant women. N Am J Med Sci., 3 (5), 238–41.
[27] Ndong-Atome, G., Makuwa, M., Njouom, R., Branger, M., Brun-Vézinet, F., Mahé, A., Kazanji, M. (2008). Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa. BMC Infectious Diseases, 8, 82.
[28] Murad, E., Babiker, S., Gasim, G., Rayis, D., & Adam, I. (2010). Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana’a, Yemen. BMC Pregnancy and Childbirth, 13: 127.
[29] Achinge, G., Malu, A., Mbaave, P., Bitto, T., Shaahu, V., Mohammed, H., & Misauno, M. (2013). Prevalence of Hepatitis C in Makurdi, North Central Nigeria. IOSR Journal of Dental and Medical Sciences, 7 (5), 2279–0861.
[30] Olokoba, A. B., Salawu, F. K, Danburam, A., Olokoba, L. B., Midala. J. K., Badung, L. H., Olatinwo, A. (2011). Hepatitis B virus infection amongst pregnant women in North-eastern Nigeria- a call for action. Niger J Clin Pract. Jan-Mar; 14 (1): 10-3. doi: 10.4103/1119-3077.79232. PMID: 21493984.
[31] Laurent, C. 1., Henzel, D., Mulanga-Kabeya, C., Maertens, G., Larouzé, B., Delaporte, E. (2001) Seroepidemiological survey of Hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int J Epidemiol. 30 (4): 872-7.
[32] Obienu, O., Nwokediuko, S., Malu, A., Lesi, O. A. (2011). Risk factors for hepatitis C virus transmission obscure in Nigerian patients. Gastroenterol Res Pract; 939673.
[33] Hladik, W., Kataaha, P., Mermin, J., Purdy, M., Otekat, G., Lackritz, E. et al (2006). Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Tropical Medicine and International Health, 11: 951-4.
Cite This Article
  • APA Style

    Ngozi Nwabuogo Anayochukwu-Ugwu, Innocent Anayochukwu Ugwu, Joseph Tochukwu Enebe. (2023). Prevalence and Risk Factors of Hepatitis C Viral Infection Among Pregnant Women at a Tertiary Institution in Lagos, Nigeria. International Journal of Infectious Diseases and Therapy, 8(1), 23-30. https://doi.org/10.11648/j.ijidt.20230801.13

    Copy | Download

    ACS Style

    Ngozi Nwabuogo Anayochukwu-Ugwu; Innocent Anayochukwu Ugwu; Joseph Tochukwu Enebe. Prevalence and Risk Factors of Hepatitis C Viral Infection Among Pregnant Women at a Tertiary Institution in Lagos, Nigeria. Int. J. Infect. Dis. Ther. 2023, 8(1), 23-30. doi: 10.11648/j.ijidt.20230801.13

    Copy | Download

    AMA Style

    Ngozi Nwabuogo Anayochukwu-Ugwu, Innocent Anayochukwu Ugwu, Joseph Tochukwu Enebe. Prevalence and Risk Factors of Hepatitis C Viral Infection Among Pregnant Women at a Tertiary Institution in Lagos, Nigeria. Int J Infect Dis Ther. 2023;8(1):23-30. doi: 10.11648/j.ijidt.20230801.13

    Copy | Download

  • @article{10.11648/j.ijidt.20230801.13,
      author = {Ngozi Nwabuogo Anayochukwu-Ugwu and Innocent Anayochukwu Ugwu and Joseph Tochukwu Enebe},
      title = {Prevalence and Risk Factors of Hepatitis C Viral Infection Among Pregnant Women at a Tertiary Institution in Lagos, Nigeria},
      journal = {International Journal of Infectious Diseases and Therapy},
      volume = {8},
      number = {1},
      pages = {23-30},
      doi = {10.11648/j.ijidt.20230801.13},
      url = {https://doi.org/10.11648/j.ijidt.20230801.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijidt.20230801.13},
      abstract = {Hepatitis C viral infection is a blood borne disease caused by Hepatitis C virus (HCV). It is significantly associated with morbidities and mortalities in men and women. Infection mostly occurs via contact with blood from transfusion of unscreened blood as well as blood products, illicit parenteral drug use (sharing of injection needles), unsafe health care and injection practices. Women who are pregnant and their unborn babies and infants are among the group of people less commonly talked about when the disease burden of HCV is being discussed in Nigeria. This study therefore aimed to ascertain the prevalence of hepatitis C virus infection among the pregnant women as well as the risk factors associated with the acquisition of the infection. Four hundred consenting antenatal attendees at the Lagos Island Maternity hospital, Nigeria were recruited and their blood samples were taken for analysis. A pretested and validated semi structured questionnaire was used to obtain information on risk factors for Hepatitis C Virus infection and socio demographic characteristic of participants. Univariate analysis was performed to obtain proportions and frequencies. In order to uncover additional risk variables for HCV infection, bivariate data analysis was carried out. Chi-square test was performed to assess statistical significance which was assumed at 0.05%. The mean age of the study subjects were 30.6 years with a standard deviation of ± 5.0 years. Majority of the study subjects 133 (33.2%) were in the age group of 30-34, most of them 238 (59.5%) had tertiary education, 396 (99.0%) were married, 110 (27.5%) were traders and 329 (82.3%) were of monogamous family setting. There was an overall sero-prevalence of 1.5% among the pregnant women with a higher prevalence of 1.25% among pregnant women who had more than one delivery (multiparous women) and 0.25% among pregnant women who had no previous delivery (nulliparous women). The risk factors that were significantly associated with the transmission of HCV infection included “Tattoo/Scarification (P=0.002) and “sharing of sharps and needles” (P=0.015). There is the need for effective public education on the ways of spread of HCV virus, practice of universal precautionary measures, adequate sterilization of instruments, appropriate use of injections, safe disposal of waste and sharps and avoidance of other high risk behavior that may lead to HCV infection. A more lager studies on the epidemiology of HCV infection is needed to inform health policy makers on strategies for prevention, screening, control and treatment of HCV infection.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Prevalence and Risk Factors of Hepatitis C Viral Infection Among Pregnant Women at a Tertiary Institution in Lagos, Nigeria
    AU  - Ngozi Nwabuogo Anayochukwu-Ugwu
    AU  - Innocent Anayochukwu Ugwu
    AU  - Joseph Tochukwu Enebe
    Y1  - 2023/02/28
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijidt.20230801.13
    DO  - 10.11648/j.ijidt.20230801.13
    T2  - International Journal of Infectious Diseases and Therapy
    JF  - International Journal of Infectious Diseases and Therapy
    JO  - International Journal of Infectious Diseases and Therapy
    SP  - 23
    EP  - 30
    PB  - Science Publishing Group
    SN  - 2578-966X
    UR  - https://doi.org/10.11648/j.ijidt.20230801.13
    AB  - Hepatitis C viral infection is a blood borne disease caused by Hepatitis C virus (HCV). It is significantly associated with morbidities and mortalities in men and women. Infection mostly occurs via contact with blood from transfusion of unscreened blood as well as blood products, illicit parenteral drug use (sharing of injection needles), unsafe health care and injection practices. Women who are pregnant and their unborn babies and infants are among the group of people less commonly talked about when the disease burden of HCV is being discussed in Nigeria. This study therefore aimed to ascertain the prevalence of hepatitis C virus infection among the pregnant women as well as the risk factors associated with the acquisition of the infection. Four hundred consenting antenatal attendees at the Lagos Island Maternity hospital, Nigeria were recruited and their blood samples were taken for analysis. A pretested and validated semi structured questionnaire was used to obtain information on risk factors for Hepatitis C Virus infection and socio demographic characteristic of participants. Univariate analysis was performed to obtain proportions and frequencies. In order to uncover additional risk variables for HCV infection, bivariate data analysis was carried out. Chi-square test was performed to assess statistical significance which was assumed at 0.05%. The mean age of the study subjects were 30.6 years with a standard deviation of ± 5.0 years. Majority of the study subjects 133 (33.2%) were in the age group of 30-34, most of them 238 (59.5%) had tertiary education, 396 (99.0%) were married, 110 (27.5%) were traders and 329 (82.3%) were of monogamous family setting. There was an overall sero-prevalence of 1.5% among the pregnant women with a higher prevalence of 1.25% among pregnant women who had more than one delivery (multiparous women) and 0.25% among pregnant women who had no previous delivery (nulliparous women). The risk factors that were significantly associated with the transmission of HCV infection included “Tattoo/Scarification (P=0.002) and “sharing of sharps and needles” (P=0.015). There is the need for effective public education on the ways of spread of HCV virus, practice of universal precautionary measures, adequate sterilization of instruments, appropriate use of injections, safe disposal of waste and sharps and avoidance of other high risk behavior that may lead to HCV infection. A more lager studies on the epidemiology of HCV infection is needed to inform health policy makers on strategies for prevention, screening, control and treatment of HCV infection.
    VL  - 8
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Medical Laboratory Science, Federal Neuropsychiatric Hospital, Enugu, Nigeria

  • Department of Obstetrics and Gynaecology, College of Medicine, Enugu State University of Science & Technology (ESUT) and ESUT Teaching Hospital, Parklane, Enugu, Nigeria

  • Department of Obstetrics and Gynaecology, College of Medicine, Enugu State University of Science & Technology (ESUT) and ESUT Teaching Hospital, Parklane, Enugu, Nigeria

  • Sections